5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow plecanatide: new trials by email Literature Review of plecanatide trials Research Report on plecanatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C) Plecanatide, Matching placebo - Irritable Bowel Syndrome With Constipation | Phase 2 | Completed | Bausch Health Americas, Inc. | 218 | 2018-06-30 | 2025-12-31 |
| An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation Plecanatide, Matching placebo - Chronic Idiopathic Constipation | Phase 2 | Completed | Bausch Health Americas, Inc. | 124 | 2017-01-01 | 2019-10-04 |
| The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Plecanatide, Placebo - Irritable Bowel Syndrome Characterized by Constipation | Phase 2 | Completed | Bausch Health Americas, Inc. | 428 | 2012-11-01 | 2019-05-28 |
| The Plecanatide Chronic Idiopathic Constipation (CIC) Study plecanatide, Placebo - Chronic Idiopathic Constipation | Phase 2 / Phase 3 | Completed | Bausch Health Americas, Inc. | 951 | 2011-10-01 | 2019-05-28 |
| SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation SP-304 0.3 mg, SP-304 1.0 mg, SP-304 3.0 mg - Chronic Idiopathic Constipation | Phase 2 | Completed | Bausch Health Americas, Inc. | 84 | 2010-03-01 | 2020-01-02 |
Constipation (2) · Irritable Bowel Syndrome (1)
Bausch Health Americas, Inc. (5)
United States (5)
Gary S Jacob, Ph.D. (1) · Philip B Miner, MD (1)